Sweden
· Delayed Price · Currency is SEK AcouSort AB Company Description
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets.
It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples.
The company has collaboration agreement with global life science company to develop cell therapy. AcouSort AB and Bio-ReCell Ltd. announced that the two companies have signed a Letter of Intent to jointly develop a system for automated clean-up and isolation of stem cells and immune cells from adipose tissue.
AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.
| Country | Sweden |
| Founded | 2010 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Torsten Freltoft |
Contact Details
Address: Medicon Village Lund, 223 81 Sweden | |
| Phone | 46 45 20 45 08 54 |
| Website | acousort.com |
Stock Details
| Ticker Symbol | ACOU |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009189608 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Torsten Freltoft | Chief Executive Officer |
| Prof. Thomas Laurell | Founder and Independent Director |
| Dr. Stefan Scheding | Founder and Independent Director |
| Prof. Patrik Brundin M.D., Ph.D. | Founder |
| Dr. Hans Lilja | Founder |
| Gunnar Telhammar | Chief Financial Officer |
| Henrik Johansson Ph.D. | Director of Research and Technology |